Clinical value of 18F-FDG PET/CT for the prognosis of colorectal cancer
10.3760/cma.j.issn.2095-2848.2018.04.017
- VernacularTitle:18F-FDG PET/CT对结直肠癌临床预后的应用价值
- Author:
Zhongqiu GUO
1
;
Tao WANG
;
Changjing ZUO
Author Information
1. 第二军医大学附属长海医院核医学科
- Keywords:
Colorectal neoplasms;
Prognosis;
Positron-emission tomography;
Tomography,X-ray computed;
Deoxyglucose
- From:
Chinese Journal of Nuclear Medicine and Molecular Imaging
2018;38(4):287-290
- CountryChina
- Language:Chinese
-
Abstract:
18F-flurodeoxyglucose(FDG) PET/CT plays an important role in early diagnosis,clinical staging,therapeutic efficacy evaluation,and recurrence monitoring of colorectal cancer (CRC).More and more scholars have focused on the value of PET/CT in CRC prognosis,intending to find out whether PET/CT can predict the survival outcomes (disease-free survival,progression-free survival and overall survival) of CRC patients after radical resection,in liver metastasis stage or in multiple metastases stage.This review summarizes the clinical value of 18F-FDG PET/CT for the prognosis of CRC.
